{
    "title": "GSK eyes Spero's experimental urinary tract infection drug, takes stake",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11238117/GSK-eyes-Speros-experimental-urinary-tract-infection-drug-takes-stake.html",
    "date": "2022-09-22",
    "keywords": [
        "spero",
        "gsk",
        "part",
        "drug",
        "tebipenem",
        "hbr",
        "latestage",
        "thursday",
        "study",
        "treatment",
        "drugmaker",
        "stake",
        "licensing",
        "agreement",
        "tract",
        "upfront",
        "deal",
        "disease",
        "strategy",
        "commitment",
        "portfolio",
        "officer",
        "luke",
        "statement",
        "june",
        "food",
        "administration",
        "trial",
        "track",
        "designation",
        "agency",
        "cuti",
        "pyelonephritis",
        "share",
        "ownership",
        "wednesday",
        "trade",
        "market",
        "weakness",
        "pharma",
        "co",
        "ltd",
        "subclass",
        "reporting",
        "karimi",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}